Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00617682 · ClinicalTrials.gov registry record · Phase 1
Maternal Immunization To Prevent Infant Otitis Media
A Phase 1 study, sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD).
- Completed
- Registry status
- Phase 1
- Development phase
- 153
- Enrollment target
NCT00617682 is a Phase 1 study that has completed, run by National Institute on Deafness and Other Communication Disorders (NIDCD). The registered enrollment target is 153 participants.
The verdict
NCT00617682, a Phase 1 study, has completed, sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 153 participants
- Enrollment target
Study Summary
The main objective of this study is to evaluate whether immunization with 9-valent pneumococcal conjugate vaccine (PNCRM9) during the third trimester of pregnancy interferes with active antibody production in offspring immunized with PNCRM7 (Prevnar) in the first six months of life.
Interventions
- BIOLOGICAL Placebo comparator
- BIOLOGICAL PNCRM9
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2000-10 |
| Est. Completion | 2004-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00617682
The ClinicalTrials.gov registry entry for NCT00617682 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Deafness and Other Communication Disorders (NIDCD), which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo comparator is the first listed.
NCT00617682 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00617682 about?
NCT00617682 is a clinical study titled "Maternal Immunization To Prevent Infant Otitis Media". The main objective of this study is to evaluate whether immunization with 9-valent pneumococcal conjugate vaccine (PNCRM9) during the third trimester of pregnancy interferes with active antibody production in offspring immunized with PNCRM7 (Prevnar) in the first six months of life.
What is the current status of trial NCT00617682?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 153 participants. The study started on 2000-10. Estimated completion is 2004-12.
What interventions are being tested in trial NCT00617682?
The interventions under investigation include: Placebo comparator (BIOLOGICAL), PNCRM9 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00617682?
This trial is sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD), which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.